Cross-Platform Evaluation Reveals Sample Preparation-Driven Biological Biases despite Advances in Mass Spectrometry Performance in Serum Proteomics.

Published 10/01/2026

Research record: Cross-Platform Evaluation Reveals Sample Preparation-Driven Biological Biases despite Advances in Mass Spectrometry Performance in Serum Proteomics.

Published in J Proteome Res; first publication date 2026-10-01. PMID 42918118.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-01

Updated

2026-10-26

Disclaimer

professional use

References

Explore more

Serum metabolomic signatures associated with gastric signet-ring cell carcinoma: A dual-platform mass spectrometry study.

Comparison of mtLSU-rRNA gene-based real-time PCR and nested PCR for the diagnosis of Pneumocystis jirovecii pneumonia in HIV-negative patients.

Clinical performance evaluation of a high-throughput real-time PCR platform for congenital cytomegalovirus screening on saliva swabs with quantitative reporting thresholds.